The Cooper Companies (COO) to Report Fiscal Q1 Earnings on Upbeat Guidance

The Cooper Companies, Inc. (COO), a medical device firm focused on vision and women’s health, is set to announce its fiscal Q1 2026 earnings. Analysts expect a profit of $1.03 per share, up 12% from the prior year, with revenue projected at $1.1 billion. The company recently reported strong Q4 results, with adjusted EPS of $1.15 exceeding expectations by 3.6%. For fiscal 2026, analysts forecast EPS of $4.51, growing 9.5% year-over-year, and $4.91 for fiscal 2027. COO shares have declined 13% over the past year, underperforming both the S&P 500 and the State Street Health Care ETF. However, Wall Street analysts remain moderately optimistic, assigning an average price target of $90.12, implying an 8.8% upside. Among 17 analysts, nine recommend "Strong Buy," while one advises "Strong Sell." The company’s robust guidance and recent performance may bolster investor confidence ahead of the earnings release.